A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Omeprazole Magnesium, Amoxicillin and Rifabutin (Talicia)

Rifamycin Antimycobacterial class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2020-03-09
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$4.86/unit
1 NDCs benchmarked, lowest of all strengths.
Average NADAC
$4.86
Across all dosage forms in distribution.
Highest NADAC
$4.86
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Omeprazole Magnesium, Amoxicillin and Rifabutin used for?

Omeprazole Magnesium, Amoxicillin and Rifabutin is a Rifamycin Antimycobacterial medication tracked in Medicare Part D.

Is there a generic for Omeprazole Magnesium, Amoxicillin and Rifabutin?

No. Omeprazole Magnesium, Amoxicillin and Rifabutin is brand-only with no generic equivalents currently in market.

How much does my plan pay for Omeprazole Magnesium, Amoxicillin and Rifabutin?

Across 329 Part D plans, Omeprazole Magnesium, Amoxicillin and Rifabutin averages $4.86/unit (NADAC). Lowest available: $4.86/unit. Highest in distribution: $4.86/unit.

Is Omeprazole Magnesium, Amoxicillin and Rifabutin on the FDA shortage list?

No. Omeprazole Magnesium, Amoxicillin and Rifabutin is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Rifamycin Antimycobacterial2 alternatives in D1
01
Rifabutin
Rifamycin Antimycobacterial
$9.18Lowest NADAC
1Generic mfrs
$10.4MCY24 Part D spend
Compare →
02
Rifapentine
Brand: Priftin
$4.85Lowest NADAC
0Generic mfrs
$818,510CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.